ResMed Inc.
RMD
$251.69
$3.111.25%
NYSE
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Revenue | 7.92% | 10.26% | 11.08% | 9.01% | 7.17% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 7.92% | 10.26% | 11.08% | 9.01% | 7.17% |
| Cost of Revenue | 4.33% | 3.07% | 1.27% | 0.69% | 1.13% |
| Gross Profit | 10.46% | 15.83% | 19.04% | 15.62% | 11.90% |
| SG&A Expenses | 6.69% | 8.76% | 7.23% | 0.62% | 0.64% |
| Depreciation & Amortization | -3.56% | -5.81% | -10.81% | -7.07% | -7.28% |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 5.24% | 5.02% | 2.94% | 0.74% | 0.76% |
| Operating Income | 13.80% | 22.96% | 34.02% | 33.18% | 24.58% |
| Income Before Tax | 11.26% | 61.23% | 40.89% | 29.24% | 29.73% |
| Income Tax Expenses | -29.73% | 45.50% | 36.71% | 38.95% | 31.74% |
| Earnings from Continuing Operations | 21.48% | 65.05% | 41.90% | 27.25% | 29.24% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 21.48% | 65.05% | 41.90% | 27.25% | 29.24% |
| EBIT | 13.80% | 22.96% | 34.02% | 33.18% | 24.58% |
| EBITDA | 12.74% | 21.24% | 30.17% | 28.26% | 21.66% |
| EPS Basic | 21.68% | 65.41% | 42.11% | 27.33% | 29.20% |
| Normalized Basic EPS | 17.30% | 29.21% | 41.05% | 38.77% | 27.71% |
| EPS Diluted | 21.57% | 64.89% | 41.61% | 26.89% | 29.11% |
| Normalized Diluted EPS | 17.29% | 28.99% | 40.73% | 38.68% | 27.71% |
| Average Basic Shares Outstanding | -0.16% | -0.22% | -0.15% | -0.07% | 0.03% |
| Average Diluted Shares Outstanding | -0.16% | -0.04% | 0.08% | -0.01% | 0.04% |
| Dividend Per Share | 10.42% | 10.42% | 10.42% | 9.09% | 9.09% |
| Payout Ratio | -0.09% | -0.33% | -0.22% | -0.14% | -0.16% |